Daewoong Pharmaceutical Co Ltd - Company Profile
Powered by 
All the data and insights you need on Daewoong Pharmaceutical Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Daewoong Pharmaceutical Co Ltd Strategy Report
- Understand Daewoong Pharmaceutical Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Daewoong Pharmaceutical Co Ltd patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US11433054B2 | Grant | Pharmaceutical preparation and preparation method therefor | A61K31/426; A61K47/02; A61K47/12; A61K47/34; A61K47/38; A61K9/2095; A61K9/2893; A61K9/5089 | September 06, 2022 |
| AU2021225706A1 | Application | Intermediate useful for synthesis of SGLT inhibitor and method for preparing SGLT inhibitor using same | A61K31/343; C07B2200/13; C07D307/82; C07H1/02; C07H17/04; Y02P20/55 | September 01, 2022 |
| CA3084777C | Grant | AMINO-FLUOROPIPERIDINE DERIVATIVES AS KINASE INHIBITOR | A61K31/519; A61P35/00; A61P37/00; C07D487/04 | August 30, 2022 |
| CO2022011593A2 | Application | Método de preparación de derivados de amina heterocíclica | A61K31/5377; C07D417/14 | August 30, 2022 |
| CO2022011686A2 | Application | Intermedio útil para la síntesis de un inhibidor de sglt y método para preparar un inhibidor de sglt utilizando el mismo | A61K31/343; C07B2200/13; C07D307/82; C07H1/02; C07H17/04; Y02P20/55 | August 30, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward